Minerva Neurosciences, Inc (NERV) Social Stream
Minerva Neurosciences Inc (NERV) Price Targets From Analysts
Use the tables below to see what analysts covering Minerva Neurosciences Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
NERV's average price target has moved down $3 over the prior 50 weeks.
NERV reports an average of 287.09% for its upside potential over the past 38 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NERV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, NERV's average broker recommendation rating worsened by 0.13.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NERV as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Minerva Neurosciences Inc's average analyst price target is higher than 6.32% of them.
- NERV has a higher upside potential (average analyst target price relative to current price) than 192% of all US stocks.
- Minerva Neurosciences Inc's number of analysts covering the stock is higher than 25.14% of Healthcare stocks.
- In the context of stocks in the small market cap category, Minerva Neurosciences Inc's variance in analysts' estimates is lower than -59.21% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Minerva Neurosciences Inc are NEPT, NCNA, and NBTX.
Is NERV a Buy, Hold or Sell? See the POWR Ratings now!